These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 8198880)
1. Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction-The STEMI-Lipids Study. Sourij C; Aziz F; Krappinger S; Praschk A; Metzner T; Kojzar H; Zirlik A; Stojakovic T; Pätzold D; von Lewinski D; Zweiker R; Scharnagl H; Sourij H Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958516 [TBL] [Abstract][Full Text] [Related]
2. Frequency of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease. Upadhyaya B; Wang Y; Bruckel J; Block RC J Clin Lipidol; 2023; 17(6):743-747. PubMed ID: 37783648 [TBL] [Abstract][Full Text] [Related]
3. Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults. Yuen T; Mancini GBJ; Hegele RA; Pearson GJ CJC Open; 2024 Mar; 6(3):597-606. PubMed ID: 38559332 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? Boffa MB; Koschinsky ML J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358 [TBL] [Abstract][Full Text] [Related]
5. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
6. Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction. MBewu AD; Durrington PN; Mackness MI; Hunt L; Turkie WH; Creamer JE Br Heart J; 1994 Apr; 71(4):316-21. PubMed ID: 8198880 [TBL] [Abstract][Full Text] [Related]
7. The effect of lipoprotein-a on thrombolytic therapy and spontaneous reperfusion in acute myocardial infarction. A comparative study. Dagdelen S; Eren N; Akdemir I; Karabulut H; Ergelen M; Caglar N Int Angiol; 2002 Dec; 21(4):384-9. PubMed ID: 12518121 [TBL] [Abstract][Full Text] [Related]
8. Does increased lipoprotein (a) impair the effectiveness of thrombolysis with streptokinase? Tokgözoğlu SL; Ozmen F; Kabukçu M; Karanfil A; Aytemir K; Ozkuyumcu C; Uğurlu S Angiology; 1995 Aug; 46(8):727-31. PubMed ID: 7639420 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Qiu SQ; Théroux P; Genest J; Solymoss BC; Robitaille D; Marcil M Am J Cardiol; 1991 Jun; 67(15):1175-9. PubMed ID: 1827942 [TBL] [Abstract][Full Text] [Related]
11. The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein. MBewu AD; Durrington PN; Bulleid S; Mackness MI Atherosclerosis; 1993 Oct; 103(1):65-71. PubMed ID: 8280186 [TBL] [Abstract][Full Text] [Related]
12. Assessment of jeopardized myocardium in patients with one-vessel disease. Iskandrian AS; Lichtenberg R; Segal BL; Mintz GS; Mundth ED; Hakki AH; Kimbiris D; Bemis CE; Croll MN; Kane SA Circulation; 1982 Feb; 65(2):242-7. PubMed ID: 7053881 [No Abstract] [Full Text] [Related]